This is early beta for now! Can't handle all templates properly

Hankkija

Vastaanotettu Hilmaan2019-12-31
Ilmoituksen numero2019-008936
TED numero2019/S 080-191763
OstajaorganisaatioNational Institute for Health and Welfare (2229500-6 )
PL 30
FI-00271 Helsinki
https://thl.fi/en/web/thlfi-en
Hankinnan otsikkotiedotHuman Papillomavirus Vaccine (HPV) 2019-2020 (2020-2021)
Hankinnan yhteenlaskettu kokonaisarvo koko ajalle (ilman alv:ta) arvio
Hankinnan yhteenlaskettu kokonaisarvo koko ajalle (ilman alv:ta) lopullinen1 447 600 EUR
Alkuperäinen ilmoitushttps://www.hankintailmoitukset.fi/en/public/procurement/11303/notice/21391/overview
Originaali JSON tietue21391.json

Ostettava

Hankinnan lyhyt kuvausThe purpose of STM and the Customer is to procure Human Papillomavirus Vaccine (HPV) required for the National Vaccination Programme in Finland. The Customer will implement the procurement on STM´s side. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority". The contract will be awarded to one Supplier based on a comparison of tenders. Estimated quantity for the contract period is 47 000 doses. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The estimated duration of the contract is about one year. After the contract period, the Customer reserves the right for the option described in section "Information about additional procurement options". Please notice that in the section "II.2.5. Award criteria" Price means the reference price. Tenders will be compared in the manner described in section "Grounds for decision" of the Invitation to tender.
Hankintanimikkeistö (CPV) pää
Hankintanimikkeistö (CPV) muut
AluekoodiFI
Pääasiallinen suorituspaikka

Sopimukset

Päätös päivämäärä2019-03-25
Sopimusnumero
MyyjätGlaxoSmithKline Oy (FI),  0108378-4